Colchicine in Acute Myocardial Infarction
Sanjit S. Jolly(Population Health Research Institute), Salim Yusuf(Population Health Research Institute), Timothy D. Henry(Christ Hospital), Biljana Zafirovska(Ss. Cyril and Methodius University in Skopje), Marc-André d’Entremont(Centre Hospitalier Universitaire de Sherbrooke), Rajibul Mian(Population Health Research Institute), Jan H. Cornel(Brigham and Women's Hospital), Sanjib Kumar Sharma(B.P. Koirala Institute of Health Sciences), Gilles Montalescot(Maastricht University Medical Centre), Jessica Tyrwhitt(Population Health Research Institute), Shun Fu Lee(Population Health Research Institute), Robert F. Storey(University of Sheffield), P.J. Devereaux(University of Limerick), Goran Stanković(University of Belgrade), Binita Shah(New York University), Shamir R. Mehta(Population Health Research Institute), Petr Kala(Masaryk University), Jamie Layland(Peninsula Health), Sasko Kedev(Ss. Cyril and Methodius University in Skopje), Sarah Tawadros(Population Health Research Institute), Shahar Lavi(London Health Sciences Centre), Wadea Tarhuni(SaskWater), David Conen(Population Health Research Institute), John W. Eikelboom(Population Health Research Institute), Raúl Moreno(Hospital Universitario La Paz), John A. Cairns, Tej Sheth(McMaster University), Matthias Bossard(University of Lucerne)
Cited by 289
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k